Usefulness of seroconversion rates for comparing infection pressures between countries

Epidemiology and Infection

Volumn 139, Issue 4, 2011, Pages 636-643

  Simonsen, J ^a   Teunis, P ^b,c   Van Pelt, W ^b   Van Duynhoven, Y ^b   Krogfelt, K A ^a   Sadkowska Todys, M ^d   Molbak K ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c EMORY UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

ELISA; mathematical modelling; salmonellosis; serology

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DENMARK; DISEASE SURVEILLANCE; FREQUENCY ANALYSIS; GEOGRAPHIC DISTRIBUTION; HUMAN; NETHERLANDS; NONHUMAN; OPTICAL DENSITY; POLAND; SALMONELLA; SALMONELLOSIS; SEROCONVERSION; SEROPREVALENCE; BLOOD; COMPARATIVE STUDY; EPIDEMIOLOGY; EVALUATION; FOOD POISONING; INCIDENCE; MICROBIOLOGY;

ANTIBODIES, BACTERIAL; CROSS-SECTIONAL STUDIES; DENMARK; EPIDEMIOLOGIC METHODS; FOODBORNE DISEASES; HUMANS; INCIDENCE; NETHERLANDS; POLAND; SALMONELLA INFECTIONS; SEROEPIDEMIOLOGIC STUDIES;

EID: 79955686710     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810000750     Document Type: Article

References (14)

1. Herikstad H, et al. A population-based estimate of the burden of diarrhoeal illness in the United States : FoodNet, 1996-1997. Epidemiology and Infection 2002; 129: 9-17.
2. Scallan E. Activities, achievements, and lessons learned during the first 10 years of the Foodborne Diseases Active Surveillance Network: 1996-2005. Clinical Infectious Diseases 2007; 44: 718-725.
3. van Pelt W, et al. Laboratory surveillance of bacterial gastroenteric pathogens in the Netherlands, 1991-2001. Epidemiology and Infection 2003; 130: 431-441. (Pubitemid 36722781)
4. Wheeler J, et al. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive. British Medical Journal 1999; 318: 1046-1050. (Pubitemid 29191897)
5. MedVetNet Workpackage 32. 26 September 2006 (http://www.medvetnet.org/ cms/templates/doc.php?id=92). Accessed 23 November 2009.
6. Voetsch A, et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clinical Infectious Diseases 2004; 38: S127-S134. (Pubitemid 38553316)
7. Simonsen J, et al. Estimation of incidences of infectious diseases based on antibody measurements. Statistics in Medicine 2009; 28: 1882-1895.
8. Strid MA, et al. Kinetics of the human antibody response against Salmonella enterica serovars Enteritidis and Typhimurium determined by lipopolysaccharide enzyme-linked immunosorbent assay. Clinical and Vaccine Immunology 2007; 14: 741-747. (Pubitemid 47104763)
9. Smith JS, et al. Type specific seroprevalence of HSV-1 and HSV-2 in four geographical regions of Poland. Sexually Transmitted Infections 2006; 82: 159-163.
10. van der Klis FR, et al. Second national serum bank for population-based seroprevalence studies in the Netherlands. The Netherlands Journal of Medicine 2009; 67: 301-308.
11. Gilks WR, Richardson S, Spiegelhalter DJ. Markov Chain Monte Carlo in Practice. London: Chapman & Hall/CRC, 1996, pp. 1-15.
12. Dodds MG, Vicini P. Assessing convergence of Markov chain Monte Carlo simulations in hierarchical Bayesian models for population pharmacokinetics. Annals of Biomedical Engineering 2004; 32: 1300-1313
13. Lunn DJ. WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Statistics and Computing 2000; 10: 325-337.
14. SAS. SAS version 9.1 for Windows. SAS Institute, Cary, NC, USA, 2002-2003.